NXTS
Nexentis Technologies Inc.Basic Materials · $80K market cap
Verdict
We can't put a fair value on NXTS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow NXTS
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Oct 15, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about NXTS
Are insiders buying NXTS?
Since Oct 15, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar).
How can I check NXTS's value myself?
Use the free Sticker Price calculator, already filled with NXTS's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Agricultural Inputs
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Agricultural Inputs
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 23, 2026. How the Payback Price works